ConductScience.org, home

Paper · 25035397

Osteopontin shapes immunosuppression in the metastatic niche.

Sangaletti S and 11 others. Cancer Res, 2014. Cited by 130 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Osteopontin shapes immunosuppression in the metastatic niche. Papers, record 25035397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25035397

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Osteopontin shapes immunosuppression in the metastatic niche.
PubMed
Journal
Cancer Res
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
3.19
iCite
Revised in PubMed
2021-12-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sangaletti SSabina
2Tripodo CClaudio
3Sandri SSara
4Torselli IIlaria
5Vitali CCaterina
6Ratti CChiara
7Botti LLaura
8Burocchi AAlessia
9Porcasi RRossana
10Tomirotti AAndrea

1 to 10 of 12Source PubMed

See all 12 authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neoplasm MetastasisMajor topic
OsteopontinMajor topic
Animals
Arginase
Breast Neoplasms
Cell Line, Tumor
Female
Humans
Immune Tolerance
Immunosuppression Therapy
Interleukin-6
Lung Neoplasms
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
Monocytes
Myeloid Cells
STAT3 Transcription Factor
T-Lymphocytes, Regulatory

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
42,856,147Malignant epithelial diversification and inflammatory neutrophil remodeling define a transitional stage between tumor cell dissemination and overt metastatic outgrowth in breast cancer.bioRxiv2026https://conductscience.org/library/papers/42856147PubMed
42,509,406Single-cell and spatial transcriptomic landscapes reveal PIGT as a pivotal regulator of immunometabolic remodeling in colorectal cancer liver metastasis.Funct Integr Genomics2026https://conductscience.org/library/papers/42509406PubMed
42,469,833SPP1-positive macrophages drive trastuzumab resistance in HER2-positive breast cancer.Cell Commun Signal2026https://conductscience.org/library/papers/42469833PubMed
42,399,829Preliminary study on the mechanism of OPN up-regulating PD-L1 to induce CD8 + T cell exhaustion in synovial sarcoma.BMC Cancer2026https://conductscience.org/library/papers/42399829PubMed
42,198,359
Mechanism of Xiao-ai-fei Honey Ointment, a Traditional Uyghur Multi-Ingredient Medicinal Preparation, Against Cervical Cancer Based on Network Pharmacology and In Vitro Evaluation of Anti-Cancer Activity.
Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198359PubMed
42,148,086Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42148086PubMed
42,010,317Pathophysiological roles of monocytes and macrophages in cancer.Nat Rev Immunol2026https://conductscience.org/library/papers/42010317PubMed
41,756,888Distinct and cooperative roles of host and tumor Osteopontin in colorectal cancer liver metastasis.bioRxiv2026https://conductscience.org/library/papers/41756888PubMed
41,697,520Research progress on the correlation between OPN and immune escape of gastric cancer.Clin Exp Med2026https://conductscience.org/library/papers/41697520PubMed
41,644,583Proteomic atlas of human peritoneal tissue.Sci Rep2026https://conductscience.org/library/papers/41644583PubMed

1 to 10 of 96

See all 96 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SPP16,696PubTator's text mininghttps://conductscience.org/library/genes/6696

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25035397

GET https://conductscience.org/api/papers/v1/25035397/cited_by?page=2